VivoSim Labs, Inc. ( VIVS ), a provider of next-generation New Approach Methodologies (NAM) 3D human cellular models for preclinical safety, highlighted the FDA's updated regulations allowing greater ...
A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink. Presented today at the ESOT Congress ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results